Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 2/2013

01-02-2013 | Clinical Report

Type 2 Diabetes Mellitus in Patients with Mild Obesity: Preliminary Results of Surgical Treatment

Authors: Enrique Lanzarini, Attila Csendes, Luis Gutierrez, Pedro Cuevas, Hanns Lembach, Juan C. Molina, Maher Musleh, Italo Braghetto, Karin Papapietro, Verónica Araya, Rodolfo Lahsen, Pablo Olguin, Andrea Riffo, Emma Diaz, Denisse Montt, Luciana Marín

Published in: Obesity Surgery | Issue 2/2013

Login to get access

Abstract

In the last years, type 2 diabetes mellitus (T2DM) and obesity have become a serious public health problem, behaving as epidemic diseases. There is great interest in exploring different options for the treatment of T2DM in nonmorbidly obese patients. The purpose of this study is to report parameters of glycemic control in patients with T2DM and mild obesity who underwent laparoscopic Roux-en-Y gastric bypass (RYGBP). This prospective clinical trial includes patients with T2DM with a body mass index (BMI) between 30 and 35 kg/m2 who underwent laparoscopic RYGBP from July 2008 through October 2010. Thirty-one patients were included in the study, 15 men and 16 women, with an average age of 48.7 ± 8.6 years. The average time since onset of T2DM was 5.8 years. The average postoperative follow-up was 30.4 months. The average preoperative blood glucose and glycosylated hemoglobin were 152 ± 70 mg/dl and 7.7 ± 2.1 %, respectively. All of them were using oral hypoglycemic agents, and four patients were insulin dependent. Only one patient had a postoperative complication (hemoperitoneum). At 36 months follow-up, the average BMI decreased to 24.7 kg/m2, all patients (31) showed improvement in their glycemic control, and 29 of them (93.6 %) met the criteria for remission of T2DM in the last control. Laparoscopic RYGBP is a safe and effective procedure that improves glycemic control in patients with T2DM and mild obesity at midterm follow-up.
Literature
1.
Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab. 2003;29:9–18.CrossRef
2.
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRef
3.
Instituto Nacional de Estadisticas (National Statistics Institute, Chile). Encuesta Nacional de Salud (National Health Survey). MINSAL 2003
4.
5.
Geiss L, Herman W, Smith P. Mortality in non insulin-dependent diabetes.”Diabetes in America” 2nd edition. National diabetes data group. National Health Institutes. National Institute of Diabetes and Digestive and Kidney Diseases NIH Publication. 1995;95:1468.
6.
Haffner S, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with or without prior myocardial infarction. N Eng J Med. 1998;339:229–34.CrossRef
7.
UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet. 1998;352:854–65.CrossRef
8.
Heine R, Diamant M, Mbanya J-C, et al. Management of hyperglycemia in type 2 diabetes: the end of recurrent failure? BMJ. 2006;333:1200–4.PubMedCrossRef
9.
Dailey G, Kim M, Lian J. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res. 2002;30:71–9.PubMed
10.
Kahn S, Haffner S, Heise M, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427–43.PubMedCrossRef
11.
Dormandy J, Charbonnel B, Eckland D, et al. On behalf of the PROactive Investigators. Secondary prevention on macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279–89.PubMedCrossRef
12.
Lago R, Singh P, Nesto R. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet. 2007;370:1129–36.PubMedCrossRef
13.
Parks M, Rosenbraugh C. Weighing risks and benefits of liraglutide—the FDA’s review of a new anidiabetic therapy. N Eng J Med. 2010;362:774–7.CrossRef
14.
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554–9.PubMedCrossRef
15.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
16.
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.PubMedCrossRef
17.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.PubMedCrossRef
18.
Ramos AC. Galvao Neto MP, de Souza YM, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19:307–12.PubMedCrossRef
19.
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.PubMedCrossRef
20.
Rubino F, Schauer P, Kaplan L, et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.PubMedCrossRef
21.
Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Eng J Med. 2007;357:741–52.CrossRef
22.
Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective controlled intervention trial. Lancet Oncol. 2009;10:653–62.PubMedCrossRef
23.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef
24.
Christou NV, Sampalis JS, Liberman N, et al. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.PubMedCrossRef
25.
Csendes A, Burdiles P, Papapietro K, et al. Review of the results of medical and surgical treatment of morbid obesity. Rev Méd Chile. 2009;137:559–66.PubMed
26.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.PubMedCrossRef
27.
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.PubMedCrossRef
28.
Csendes A, Papapietro K, Burgos AM, et al. Efecto del by pass gástrico a largo plazo (7 a 10 años) en pacientes con obesidad severa y mórbida sobre el peso corporal, diabetes, dyslipidemia y desarrollo de anemia. Rev Med Chil. 2011;139:1423–9.
29.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc. 2008;299:316–23.CrossRef
30.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.PubMedCrossRef
31.
Schauer P, Kashyap S, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.PubMedCrossRef
32.
American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009;32:S13–61.CrossRef
33.
Lee W, Wang W, Lee Y, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.PubMedCrossRef
34.
DePaula A, Macedo A, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008;22:706–16.PubMedCrossRef
35.
Ramos A, Galvão M, de Souza Y, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19:307–12.PubMedCrossRef
36.
Fried M, Ribaric J, Buchwald J, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20:776–90.PubMedCrossRef
37.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.PubMedCrossRef
38.
Reis C, Alvarez-Leite J, Bressan J, et al. Role of bariatric–metabolic surgery in the treatment of obese type 2 diabetes with body mass index < 35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14:365–72.PubMedCrossRef
39.
Lee WJ, Yul Hur K, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–62.PubMedCrossRef
40.
Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621–32.PubMedCrossRef
41.
Nguyen NT, Hinojosa M, Fayad C, et al. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007;205:248–55.PubMedCrossRef
42.
Lanzarini E, Csendes A, Lembach H, et al. Evolution of type 2 diabetes mellitus in non morbid gastrectomized patients with Roux en Y reconstruction: retrospective study. World J Surg. 2010;34:2098–102.PubMedCrossRef
Metadata
Title
Type 2 Diabetes Mellitus in Patients with Mild Obesity: Preliminary Results of Surgical Treatment
Authors
Enrique Lanzarini
Attila Csendes
Luis Gutierrez
Pedro Cuevas
Hanns Lembach
Juan C. Molina
Maher Musleh
Italo Braghetto
Karin Papapietro
Verónica Araya
Rodolfo Lahsen
Pablo Olguin
Andrea Riffo
Emma Diaz
Denisse Montt
Luciana Marín
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 2/2013
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0780-3

Other articles of this Issue 2/2013

Obesity Surgery 2/2013 Go to the issue

Clinical Research

Effectiveness of Bariatric Surgery in Reducing Weight and Body Mass Index Among Hispanic Adolescents

Clinical Research

Short- and Long-Term Outcomes of Vertical Banded Gastroplasty Converted to Roux-en-Y Gastric Bypass

Clinical Research

Racial Differences Among Patients Undergoing Laparoscopic Gastric Bypass Surgery: a Population-Based Trend Analysis from 2002 to 2008

New Concept

Initial Experience of Single-Port Surgery Assisted by Percutaneous Instruments for Gastric Bypass: a Combination of Safety and Minimally Invasive Surgery

Erratum

Erratum to: Differential Changes in Exercise Performance After Massive Weight Loss Induced by Bariatric Surgery

Clinical Research

Laparoscopic Greater Curve Plication in Asia: Initial Experience